Bowhead Specialty (BOW) Competitors

Bowhead Specialty (NYSE:BOW) and Oscar Health (NYSE:OSCR) are both finance companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability.

Which has more risk and volatility, BOW or OSCR?

Bowhead Specialty has a beta of -0.69, meaning that its stock price is 169% less volatile than the S&P 500. Comparatively, Oscar Health has a beta of 1.86, meaning that its stock price is 86% more volatile than the S&P 500.

Which has higher valuation & earnings, BOW or OSCR?

Bowhead Specialty has higher earnings, but lower revenue than Oscar Health. Bowhead Specialty is trading at a lower price-to-earnings ratio than Oscar Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bowhead Specialty	$425.66M	2.50	$38.24M	$1.31	24.80
Oscar Health	$9.18B	0.38	$25.43M	$0.28	49.46

Does the media refer more to BOW or OSCR?

In the previous week, Oscar Health had 7 more articles in the media than Bowhead Specialty. MarketBeat recorded 12 mentions for Oscar Health and 5 mentions for Bowhead Specialty. Oscar Health's average media sentiment score of 0.55 beat Bowhead Specialty's score of 0.35 indicating that Oscar Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bowhead Specialty	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Oscar Health	5 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals & insiders hold more shares of BOW or OSCR?

75.7% of Oscar Health shares are held by institutional investors. 25.1% of Oscar Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Is BOW or OSCR more profitable?

Bowhead Specialty has a net margin of 9.32% compared to Oscar Health's net margin of 1.22%. Bowhead Specialty's return on equity of 12.52% beat Oscar Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bowhead Specialty	9.32%	12.52%	2.89%
Oscar Health	1.22%	10.59%	2.45%

Do analysts prefer BOW or OSCR?

Bowhead Specialty currently has a consensus price target of $39.67, suggesting a potential upside of 22.09%. Oscar Health has a consensus price target of $12.21, suggesting a potential downside of 11.81%. Given Bowhead Specialty's stronger consensus rating and higher possible upside, analysts plainly believe Bowhead Specialty is more favorable than Oscar Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bowhead Specialty	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67
Oscar Health	5 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.44

Summary

Bowhead Specialty beats Oscar Health on 9 of the 16 factors compared between the two stocks.